News Releases

  • 08 Feb 2016
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, has hired Andrew G. Long as senior vice president and global business controller. Long will report to Stuart Grant, chief financial officer for Patheon, and will be based at the company’s headquarters in Durham, N.C. Long will focus on Patheon’s financial planning and performance management toolsmore...
  • 02 Feb 2016

    Industry Veteran, Steve Lam, to Direct Rapidly Expanding Business

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon today announced the appointment of Steve Lam as senior vice president of the company’s biologics business. Lam will report to Lukas Utiger, president of the company’s Drug Substance Services (DSS) segment, effective immediately. Biologics is a fast-growing area of the industry, which requires experience and expertise because of their complexity. For the past 18 years, Lam has served as vice president of operations for Amgen, onemore...
  • 11 Jan 2016

    Gilles Cottier to lead the company’s PDS business

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon announced today the appointment of Gilles Cottier as president of the company’s pharmaceutical development services (PDS) division effective immediately. He will serve as a member of Patheon’s executive committee and will report to Patheon CEO James Mullen. The appointment of Cottier is part of a larger realignment effort by the company to create three distinct business segments – drug product services (DPS), drug substance services (more...